[The effect of ticlopidine and lysine acetylsalicylate on fibrinolytic activity of the arterial wall in experimental atherosclerosis].
D000818:Animals; D001161:Arteriosclerosis / Q000503:physiopathology*; D001241:Aspirin / Q000031:analogs & derivatives* / Q000494:pharmacology; D005342:Fibrinolysis / Q000187:drug effects*; D008239:Lysine / Q000031:analogs & derivatives* / Q000494:pharmacology; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D011817:Rabbits; D013876:Thiophenes / Q000494:pharmacology*; D013988:Ticlopidine
D013876:Thiophenes; D008239:Lysine; D013988:Ticlopidine; D001241:Aspirin; C010395:acetylsalicylic acid lysinate
Influencia de la ticlopidina y del acetilsalicilato de lisina en la actividad fibrinolítica de la pared arterial en la ateromatosis experimental.